Skip to content

13F-HR filed by Canaan Partners XI LLC

Canaan Partners XI LLC filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-10-11, with 5 holding rows worth $114,015,007.

Accession
0000950123-23-008794
Filed
2023-10-11
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2023

A holdings report, 5 entries on the cover page, a total value of $114,015,007 stated on the cover page (in dollars after the unit check, H1), rows summing to $114,015,007 with VALUE read as dollars as filed, 13F file number 028-21580. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TYRA BIOSCIENCES INC90240B106COMMON STOCK4,409,991$60,725,576dollars as filed
Day One Biopharmaceuticals Inc23954D109Common Stock2,491,561$30,571,453dollars as filed
AEVA TECHNOLOGIES INC00835Q103COM18,485,197$14,141,176dollars as filed
RALLYBIO CORP75120L100COM2,059,712$6,941,229dollars as filed
MONEYLION INC60938K304CL A75,581$1,635,573dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-23-008794this filing2023-10-11acceptance time not in the bulk data set